BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11124107)

  • 1. Management of graft-versus-host disease.
    Arai S; Vogelsang GB
    Blood Rev; 2000 Dec; 14(4):190-204. PubMed ID: 11124107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mycophenolate mofetil in treatment of graft-versus-host disease after allogeneic hematopoietic cell transplantation: analysis of 44 cases].
    Chen H; Liu KY; Liu DH; Xu LP; Han W; Chen YH; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2127-30. PubMed ID: 19080474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant.
    Kim JG; Sohn SK; Kim DH; Lee NY; Suh JS; Lee KS; Lee KB
    Eur J Haematol; 2004 Jul; 73(1):56-61. PubMed ID: 15182339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus.
    Mookerjee B; Altomonte V; Vogelsang G
    Bone Marrow Transplant; 1999 Sep; 24(5):517-20. PubMed ID: 10482936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil for the prevention and treatment of graft-versus-host disease following stem cell transplantation: preliminary findings.
    Vogelsang GB; Arai S
    Bone Marrow Transplant; 2001 Jun; 27(12):1255-62. PubMed ID: 11548843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoral psoralen ultraviolet A irradiation (PUVA) treatment of refractory oral chronic graft-versus-host disease following allogeneic stem cell transplantation.
    Menillo SA; Goldberg SL; McKiernan P; Pecora AL
    Bone Marrow Transplant; 2001 Oct; 28(8):807-8. PubMed ID: 11781637
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease.
    Krejci M; Doubek M; Buchler T; Brychtova Y; Vorlicek J; Mayer J
    Ann Hematol; 2005 Oct; 84(10):681-5. PubMed ID: 16001244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Successful treatment of refractory acute GVHD with mycophenolate mofetil after peripheral blood stem cell transplantation from the patient's one locus-mismatched mother].
    Miyoshi T; Kawano-Yamamoto C; Nagashima T; Nagai T; Komatsu N; Muroi K; Ozawa K
    Rinsho Ketsueki; 2003 Sep; 44(9):968-70. PubMed ID: 14577320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Benefits of mycophenolate mofetil for refractory graft-versus-host disease].
    Mori M; Muroi K; Matsuyama T; Oka S; Ono Y; Yamamoto C; Uesawa M; Okabe H; Matsu H; Tatara R; Kikuchi Y; Fujiwara S; Kikuchi S; Sato K; Ueda M; Toshima M; Ozaki K; Takatoku M; Nagai T; Ozawa K
    Rinsho Ketsueki; 2007 Aug; 48(8):624-31. PubMed ID: 17867298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel pharmacotherapeutic approaches to prevention and treatment of GVHD.
    Jacobsohn DA; Vogelsang GB
    Drugs; 2002; 62(6):879-89. PubMed ID: 11929336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination antithymocyte globulin and soluble TNFalpha inhibitor (etanercept) +/- mycophenolate mofetil for treatment of steroid refractory acute graft-versus-host disease.
    Kennedy GA; Butler J; Western R; Morton J; Durrant S; Hill GR
    Bone Marrow Transplant; 2006 Jun; 37(12):1143-7. PubMed ID: 16699531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Japan.
    Yanada M; Emi N; Naoe T; Sakamaki H; Takahashi S; Hirabayashi N; Hiraoka A; Kanda Y; Tanosaki R; Okamoto S; Iwato K; Atsuta Y; Hamajima N; Tanimoto M; Kato S
    Bone Marrow Transplant; 2004 Aug; 34(4):331-7. PubMed ID: 15220958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of intravenous mycophenolate mofetil for graft-versus-host disease prophylaxis in an allogeneic hematopoietic stem cell transplant recipient with an allergic reaction to cyclosporine and tacrolimus.
    Dvorak CC; Callard E; Agarwal R
    Bone Marrow Transplant; 2006 Aug; 38(3):253-4. PubMed ID: 16785867
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient.
    Basara N; Blau WI; Kiehl MG; Römer E; Rudolphi M; Bischoff M; Kirsten D; Sanchez H; Günzelmann S; Fauser AA
    Transplant Proc; 1998 Dec; 30(8):4087-9. PubMed ID: 9865306
    [No Abstract]   [Full Text] [Related]  

  • 15. Extended mycophenolate mofetil administration beyond day 30 in allogeneic hematopoietic stem cell transplantation as preemptive therapy for severe graft-versus-host disease.
    Nishikawa S; Okamura A; Yamamori M; Minagawa K; Kawamori Y; Kawano Y; Kawano H; Ono K; Katayama Y; Shimoyama M; Matsui T
    Transplant Proc; 2009 Nov; 41(9):3873-6. PubMed ID: 19917404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of infliximab-daclizumab combination for the treatment of acute and chronic graft-versus-host disease of the liver and gut.
    Rodriguez V; Anderson PM; Trotz BA; Arndt CA; Allen JA; Khan SP
    Pediatr Blood Cancer; 2007 Aug; 49(2):212-5. PubMed ID: 16261610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with tacrolimus and anti-thymocyte globulin for the treatment of steroid-resistant acute graft-versus-host disease developing during cyclosporine prophylaxis.
    Mollee P; Morton AJ; Irving I; Durrant S
    Br J Haematol; 2001 Apr; 113(1):217-23. PubMed ID: 11328304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk assessment in haematopoietic stem cell transplantation: GvHD prevention and treatment.
    Holler E
    Best Pract Res Clin Haematol; 2007 Jun; 20(2):281-94. PubMed ID: 17448962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic and therapeutic treatment of graft-versus-host disease in Japan.
    Murata M
    Int J Hematol; 2015 May; 101(5):467-86. PubMed ID: 25864188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil is effective and well tolerated in the treatment of refractory acute and chronic graft-versus-host disease.
    Takami A; Mochizuki K; Okumura H; Ito S; Suga Y; Yamazaki H; Yamazaki M; Kondo Y; Asakura H; Nakao S
    Int J Hematol; 2006 Jan; 83(1):80-5. PubMed ID: 16443558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.